Cargando…

Incidence and outcome of atrial fibrillation: diversity throughout Europe

Detalles Bibliográficos
Autores principales:	Rienstra, Michiel, Van Gelder, Isabelle C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clnical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897461/ https://www.ncbi.nlm.nih.gov/pubmed/33495786 http://dx.doi.org/10.1093/eurheartj/ehaa1078

Ejemplares similares

Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes
por: Csengeri, Dora, et al.
Publicado: (2021)

Illuminating the path from genetics to clinical outcome in Brugada syndrome
por: Postema, Pieter G, et al.
Publicado: (2021)

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial
por: Butler, Javed, et al.
Publicado: (2021)

Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation
por: Sultanian, Pedram, et al.
Publicado: (2021)

Unfolding and disentangling coronary vascular disease through genome-wide association studies
por: Erdmann, Jeanette, et al.
Publicado: (2021)

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
por: Heerspink, Hiddo J L, et al.
Publicado: (2021)

Brugada syndrome genetics is associated with phenotype severity
por: Ciconte, Giuseppe, et al.
Publicado: (2020)

Heart failure and systolic function: time to leave diagnostics based on ejection fraction?
por: Smiseth, Otto A, et al.
Publicado: (2021)

Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
por: Marx, Nikolaus, et al.
Publicado: (2021)

Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study
por: Wartolowska, Karolina Agnieszka, et al.
Publicado: (2020)

The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease
por: Münzel, Thomas, et al.
Publicado: (2020)

Discriminatory cardiac arrest care? Patients with low socioeconomic status receive delayed cardiopulmonary resuscitation and are less likely to survive an in-hospital cardiac arrest
por: Agerström, Jens, et al.
Publicado: (2020)

Does night-time aircraft noise trigger mortality? A case-crossover study on 24 886 cardiovascular deaths
por: Saucy, Apolline, et al.
Publicado: (2020)

Noise and cardiovascular risk: nighttime aircraft noise acutely triggers cardiovascular death
por: Münzel, Thomas, et al.
Publicado: (2020)

Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis
por: Wang, Qin, et al.
Publicado: (2020)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Update on management of atrial fibrillation in heart failure: a focus on ablation
por: Mulder, Bart A, et al.
Publicado: (2022)

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
por: Marcos, Ernaldo G., et al.
Publicado: (2019)

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation
por: Siland, Joylene E., et al.
Publicado: (2020)

Relation of overweight and symptomatic atrial fibrillation: A case report
por: de Maat, Gijs E., et al.
Publicado: (2015)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study
por: Kloosterman, Mariëlle, et al.
Publicado: (2019)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation
por: Al-Jazairi, M. I. H., et al.
Publicado: (2019)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Initial experience with pulsed field ablation for atrial fibrillation
por: Magni, Federico T., et al.
Publicado: (2022)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation
por: Korenstra, Jennie, et al.
Publicado: (2016)

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
por: Rienstra, Michiel, et al.
Publicado: (2016)

First-line treatment of persistent and long-standing persistent atrial fibrillation with single-stage hybrid ablation: a 2-year follow-up study
por: Magni, Federico T, et al.
Publicado: (2021)

Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
por: Ekrami, Neda Khalilian, et al.
Publicado: (2022)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Atrial fibrillation and left atrial size and function: a Mendelian randomization study
por: van de Vegte, Yordi J., et al.
Publicado: (2021)

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures
por: Mulder, Bart A, et al.
Publicado: (2021)

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Groenewegen, Amy, et al.
Publicado: (2021)

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women
por: Siland, J. E., et al.
Publicado: (2021)

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_716ensm3vmj12npmjafgku2lbt